Table 2.
Medications Associated with the Development of Atrial Fibrillation
Drug Group | Quality of Evidence | Drugs |
---|---|---|
Cardiovascular | High | Acetylcholine, adenosinea, dobutaminea |
Moderate | Flecainide,b milrinone, propafenoneb | |
Low | Amiodarone, atenolol, digoxin, diltiazem, dopamine, dopexamine, isosorbide mononitrate, levosimendan, losartan, nesiritide, thiazide diuretics, verapamil | |
Respiratory | High | Aminophylline/theophylline |
Moderate | -- | |
Low | Albuterol, arformoterol, corticosteroids, fluticasone, ipratropium, methylprednisolonea, pseudoephedrine, salmeterol | |
Antineoplastic | High | -- |
Moderate | Amifostine, cisplatin,a interleukin-2, melphalana | |
Low | Cyclophosphamide, docetaxel, doxorubicin, 5-fluorouracil, gemcitabinea, interferon-α, lenalidomide, mitoxantrone, paclitaxel | |
CNS agents | High | -- |
Moderate | -- | |
Low | Atropine, apomorphinea, clozapine, fluoxetine, lacosamide, olanzapine, physostigminea, sumatriptan,a tranylcypromine, trazodone | |
Genitourinary | High | -- |
Moderate | -- | |
Low | Sildenafil, vardenafil | |
Miscellaneous | High | Alcoholc |
Moderate | -- | |
Low | Azathioprineb, anabolic steroidsa, bisphosphonates, caffeine, etanercept, nicotine, pentagastrin |
Medications reported in van der Hooft, 2004[5] with further evidence documented after 2004.
Atrial flutter
Predominantly alcohol binging
H = High; L = Low; M = Moderate